Not just ankle osteoarthritis: recognizing subtalar joint arthritis behind lingering hindfoot pain — Dr. Moriwaki organizes the differential, the post-traumatic and chronic instability background, and subtalar joint injection with stem cell conditioned media as a conservative option2026.07.26
A deep, nagging ache just below the outer ankle bone that worsens on stairs or uneven ground is often mistaken for ankle osteoarthritis. In reality, the culprit is frequently subtalar joint arthritis — degeneration of the joint between the talus and the calcaneus. It can progress silently over years after a calcaneal fracture or repeated sprains, and it is often missed on plain X-rays. This article organizes how to distinguish subtalar joint arthritis from ankle joint disease, and outlines subtalar joint injection with stem cell conditioned media as a conservative option, from Dr. Moriwaki’s clinical perspective.
Key points of this article
・Subtalar joint arthritis is osteoarthritis of the talocalcaneal joint and is commonly confused with tibiotalar (ankle) joint disease.
・Post-traumatic degeneration after calcaneal or talar fracture, chronic ankle instability, and rheumatoid arthritis are typical background factors.
・Pain reproduced by tilting the heel inward or outward — rather than by dorsiflexion/plantarflexion — is a key clue that distinguishes subtalar joint arthritis from ankle osteoarthritis.
・Rather than relying on repeated steroid injections, orthoses, or shockwave therapy alone, subtalar joint injection with stem cell conditioned media can be considered as one option.
・The essential mindset is to explore how far conservative care can go before choosing arthrodesis, and to design that progression carefully.
What is subtalar joint arthritis and where does it hurt?
The joints around the ankle can be broadly divided into the ankle joint (tibiotalar joint — tibia, fibula, talus) and the subtalar joint (talocalcaneal joint — talus and calcaneus). While the ankle joint provides dorsiflexion and plantarflexion, the subtalar joint governs inversion and eversion of the heel. On uneven ground or slopes, the subtalar joint is constantly making fine-tuning adjustments to keep the foot balanced.
When subtalar joint arthritis progresses, the following symptoms are typical:
・Deep pain just below the outer ankle bone, spreading around the sides of the heel
・Worsening on stairs, gravel, grass, or other uneven terrain
・Pain when the heel is tilted inward or outward (inversion or eversion)
・Morning stiffness in the first steps, easing after moving around for a while
How to tell it apart from ankle osteoarthritis
Ankle osteoarthritis (tibiotalar OA) typically hurts with dorsiflexion/plantarflexion, produces swelling at the front of the ankle, and worsens on squatting. Subtalar joint arthritis, in contrast, hurts with side-to-side motion rather than up/down, worsens on uneven ground, and shifts with heel height. On examination, the subtalar inversion/eversion test — stabilizing the lower leg with one hand and tilting the heel with the other — reproduces the pain. Because plain X-rays do not always show the subtalar joint space well, CT or MRI is often needed to assess joint surface integrity and bone marrow edema.
Background factors that lead to subtalar joint arthritis
Post-traumatic degeneration after calcaneal or talar fracture
Patients who sustained a calcaneal or talar fracture in earlier years may retain slight incongruity of the joint surface, which can slowly progress to subtalar joint arthritis over several to more than a decade. Even millimeter-scale surface misalignment in a weight-bearing joint can drive cartilage degeneration over time.
Secondary degeneration from chronic ankle instability
Repeated ankle sprains weaken not only the lateral ankle ligaments (such as the anterior talofibular ligament) but also affect the stability of the subtalar joint itself. Ongoing micro-instability at the subtalar joint stresses the cartilage and capsule and accelerates degeneration.
Rheumatoid arthritis and inflammatory arthritis
Inflammatory arthritides such as rheumatoid arthritis and ankylosing spondylitis are well known to cause synovitis in the ankle and subtalar joints. In these cases, controlling the underlying systemic disease takes priority, and subtalar joint injection with stem cell conditioned media has an adjunctive role.
Subtalar joint injection with stem cell conditioned media as an option
Conservative care for subtalar joint arthritis has traditionally centered on orthoses (insoles, hindfoot braces), NSAIDs, intra-articular steroid injections, and extracorporeal shockwave therapy. However, repeated steroid injections raise concerns about their impact on cartilage and surrounding tendons and are not always sufficient to sustain daily function over the long term.
This is where subtalar joint injection with stem cell conditioned media enters the discussion. Stem cell conditioned media contains growth factors such as TGF-β, IGF-1, and FGF, along with anti-inflammatory cytokines and extracellular vesicles (exosomes), and is thought to act on the intra-articular inflammatory cycle and help modulate the synovial environment. The right framing is not that the injection regenerates cartilage from scratch, but that it addresses the intra-articular environment that generates pain.
Injection technique and evaluation timing
Because the subtalar joint is narrow with limited range of motion, injection into it demands anatomical precision. An ultrasound-guided approach is preferable to minimize extra-articular leakage. Response is typically evaluated 4 to 8 weeks after injection using pain scores (NRS), range of motion, and functional activities such as stair climbing and walking on uneven ground. When a single injection does not clearly change symptoms, a series of 2 to 3 injections may be considered.
Limits and non-indications
Care is warranted in cases with severe joint destruction (end-stage incongruity), active infection, or poorly controlled systemic disease. If a patient has already reached a stage where subtalar arthrodesis is genuinely appropriate, orthopedic surgical judgment should take precedence over pushing conservative care with stem cell conditioned media. For clinical guidance, please also refer to the Japanese Orthopaedic Association.
Sequence of care and how to combine treatments
Care for subtalar joint arthritis usually proceeds through five steps: (1) confirming the diagnosis with imaging and clinical findings, (2) reviewing loading and footwear, (3) rehabilitation and orthoses, (4) injection therapy, and (5) surgery. Subtalar joint injection with stem cell conditioned media fits in step (4), when patients want to avoid repeated steroid injections or wish to try one more conservative option before turning to surgery.
Combining the injection with insoles that correct hindfoot alignment (inversion/eversion), hindfoot bracing, and rehabilitation of the gluteus medius and tibialis posterior tends to sustain the therapeutic effect longer than injection alone. Shifting from “cure it with an injection” to “use the injection to calm inflammation while training stabilizes the foundation” is a realistic approach to managing subtalar joint arthritis as a long-term condition.
For related columns on stem cell conditioned media joint injections, please also see more on joint injections with stem cell conditioned media here.
Frequently asked questions
Q. What happens if subtalar joint arthritis is left untreated?
As cartilage degeneration advances, joint surface incongruity worsens, and range-of-motion restrictions and chronic pain can settle in. Compensatory gait then places extra stress on the ankle, knee, and hip, so early diagnosis and initiation of conservative care are recommended.
Q. Is subtalar joint injection with stem cell conditioned media covered by insurance?
It is provided as private-pay care under a regenerative medicine provision plan. Costs vary by facility, number of sessions, and product source, so please confirm the total budget and the follow-up schedule at your consultation.
Q. Can I exercise after the injection?
Heavy exercise and long walks are usually avoided on the day of injection, and normal activity is resumed gradually within a tolerable pain range from the next day. Continuing to use orthoses and insoles helps prevent recurrence.
Q. What interval should the injections be spaced at?
An induction phase of 2 to 3 injections at 2 to 4-week intervals is common, followed by a maintenance interval of several months to half a year depending on symptoms and activity. Response varies among individuals, and additional injections are considered according to the degree of improvement.
Q. How does it differ from subtalar arthrodesis?
Arthrodesis is a definitive surgery that stops the painful joint from moving; it is highly reliable but sacrifices motion. Subtalar joint injection with stem cell conditioned media is a conservative option that aims to calm inflammation while preserving mobility and function, and can be considered before committing to surgery.
──────────────
Supervising physician: Shin Moriwaki, MD
Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine / ECFMG certificate
──────────────
📍AVAN TOKYO Ginza Regenerative Medicine
English / 中文 / Tiếng Việt available
Please contact us via DM / LINE / Website / Phone.